About 12,100,000 results
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
Novartis Kisqali® shows deepening benefit in new analysis, …
News - Novartis
Novartis unveils new focused strategy, underpinned by eight …
Novartis’ Kisqali gets expanded FDA OK; Mene Pangalos joins …
New Novartis data in relapsing MS reinforce benefits of …
Novartis AG: Hold Rating Justified Amid Kisqali’s Market Potential …
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two ... - BioSpace
Novartis raises 2023 forecast, maps out Sandoz spin-off